Citadel Advisors’s XORTX Therapeutics XRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $35.8K | Buy |
+38,468
| New | +$35.8K | ﹤0.01% | 5540 |
|
2024
Q3 | – | Sell |
-12,333
| Closed | -$23.3K | – | 6832 |
|
2024
Q2 | $23.3K | Buy |
+12,333
| New | +$23.3K | ﹤0.01% | 5371 |
|
2023
Q3 | – | Sell |
-347
| Closed | -$18.3K | – | 6605 |
|
2023
Q2 | $18.3K | Buy |
+347
| New | +$18.3K | ﹤0.01% | 5277 |
|
2023
Q1 | – | Sell |
-218
| Closed | -$14.7K | – | 6646 |
|
2022
Q4 | $14.7K | Buy |
+218
| New | +$14.7K | ﹤0.01% | 5608 |
|